Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00476112
Status:
COMPLETED
Last Update Posted:
2008-04-02
First Post:
2007-05-18
Brief Title:
A Phase IIIII Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Flutter
Sponsor:
Advanz Pharma
Organization:
Advanz Pharma
Organization Data
Organization:
Advanz Pharma
Class:
INDUSTRY
Study ID:
1235-0703B
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Advanz Pharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Sheila Grant VP of Product Development Vernakalant
Old Organization:
Cardiome Pharma Corp
Collaborators
| Name | Class |
|---|---|
| Astellas Pharma US Inc | INDUSTRY |